Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31720936 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL2722025 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubron SCHEMBL13724347 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubron SCHEMBL33826 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL7029311 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL7055048 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubron SCHEMBL8040555 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL4511229 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL249369 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL248644 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 721 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | claimed |
| EP-4744487-A1 | FLUID, METHODS OF PRODUCING FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4744486-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4704937-A1 | DEVICE FOR THE ENTERAL ABSORPTION OF CO2, AND CORRESPONDING SET | O11 biomedical GmbH (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4580680-A1 | LECITHIN-MODIFIED NANOSCALE OXYGEN CARRIERS (LENOX) | Universität Duisburg-Essen (DE) | 2025-07-09 | — | — | EP | claimed |
| US-12311407-B2 | Inertization of material surfaces by functionalized perfluorinated molecules | TECHNISCHE UNIVERSITAT BERLIN (DE) | 2025-05-27 | — | — | US | claimed |
| WO-2025093759-A1 | DEVICE FOR THE ENTERAL ABSORPTION OF CO2, AND CORRESPONDING SET | O11-BIOMEDICAL GMBH (DE) | 2025-05-08 | — | — | WO | claimed |
| CN-119498276-A | Novel organ cryopreservation liquid based on PVP (polyvinyl pyrrolidone) fluorocarbon emulsion | 北京医院 | 2025-02-25 | — | — | CN | claimed |
| WO-2024223620-A1 | NOVEL USES OF FLUOROCARBONS | Midas Pharma GmbH (DE) | 2024-10-31 | — | — | WO | claimed |
| CN-118136967-B | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-5582813-A | USEFUL FOR BIOMEDICAL APPLICATIONS, PARTICULARY RADIOGRAPHY AND SCINTIGRAPHY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-10 | — | — | US | claimed |
| US-5532420-A | Manufacture of solid perfluoroalkyl bromides | ELF ATOCHEM S.A. (FR) | 1996-07-02 | — | — | US | claimed |
| EP-0714518-A1 | METHOD OF IMPROVING FAT SATURATION DURING MRI | ALLIANCE PHARMACEUTICAL CORPORATION (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0714518-A4 | METHOD OF IMPROVING FAT SATURATION DURING MRI | ALLIANCE PHARMA (US) | 1996-04-09 | — | — | EP | claimed |
| EP-0666736-A1 | STABILIZATION OF FLUOROCARBON EMULSIONS. | ALLIANCE PHARMA (US) | 1995-08-16 | — | — | EP | claimed |
| US-5414358-A | Method of improving fat saturation during MRI | ALLIANCE PHARMACEUTICAL CORP. (US) | 1995-05-09 | — | — | US | claimed |
| US-5339033-A | Method of improving fat saturation during MRI | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-08-16 | — | — | US | claimed |
| WO-1994016742-A1 | IODINE-CONTAINING FLUOROCARBON CONTRAST AGENTS | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHNOLOGIES AVANCEES (FR) | 1994-08-04 | — | — | WO | claimed |
| WO-1994009625-A2 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-05-11 | — | — | WO | claimed |
| WO-1994004946-A1 | METHOD OF IMPROVING FAT SATURATION DURING MRI | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-03-03 | — | — | WO | claimed |